nodes	percent_of_prediction	percent_of_DWPC	metapath
Theophylline—HDAC2—melanoma	0.379	0.715	CbGaD
Theophylline—CYP1B1—melanoma	0.151	0.285	CbGaD
Theophylline—CYP1B1—Docetaxel—melanoma	0.043	0.147	CbGbCtD
Theophylline—CYP1A1—Dacarbazine—melanoma	0.0421	0.144	CbGbCtD
Theophylline—SLC22A7—Docetaxel—melanoma	0.0389	0.133	CbGbCtD
Theophylline—CYP2E1—Dacarbazine—melanoma	0.0325	0.111	CbGbCtD
Theophylline—CYP1A2—Carmustine—melanoma	0.0311	0.106	CbGbCtD
Theophylline—CYP1A2—Vemurafenib—melanoma	0.0246	0.0841	CbGbCtD
Theophylline—CYP3A4—Temozolomide—melanoma	0.0235	0.0804	CbGbCtD
Theophylline—CYP2D6—Vemurafenib—melanoma	0.0202	0.0693	CbGbCtD
Theophylline—CYP1A2—Dacarbazine—melanoma	0.0188	0.0645	CbGbCtD
Theophylline—PDE5A—clitoris—melanoma	0.014	0.379	CbGeAlD
Theophylline—CYP3A4—Vemurafenib—melanoma	0.0129	0.0441	CbGbCtD
Theophylline—CYP3A4—Docetaxel—melanoma	0.00441	0.0151	CbGbCtD
Theophylline—Status epilepticus—Temozolomide—melanoma	0.00199	0.0671	CcSEcCtD
Theophylline—Aminophylline—HDAC2—melanoma	0.00172	0.292	CrCbGaD
Theophylline—PDE5A—endothelium—melanoma	0.00155	0.042	CbGeAlD
Theophylline—PDE5A—blood vessel—melanoma	0.00143	0.0388	CbGeAlD
Theophylline—HDAC2—hair follicle—melanoma	0.00143	0.0387	CbGeAlD
Theophylline—ADORA2B—eye—melanoma	0.00101	0.0272	CbGeAlD
Theophylline—Oxtriphylline—HDAC2—melanoma	0.000989	0.168	CrCbGaD
Theophylline—HDAC2—neck—melanoma	0.00096	0.026	CbGeAlD
Theophylline—CYP1B1—hair follicle—melanoma	0.000918	0.0248	CbGeAlD
Theophylline—CYP1A1—skin epidermis—melanoma	0.000909	0.0246	CbGeAlD
Theophylline—Caffeine—ATM—melanoma	0.000813	0.138	CrCbGaD
Theophylline—ADORA2B—mammalian vulva—melanoma	0.000798	0.0216	CbGeAlD
Theophylline—Sinus tachycardia—Docetaxel—melanoma	0.000775	0.0261	CcSEcCtD
Theophylline—PDE5A—eye—melanoma	0.000762	0.0206	CbGeAlD
Theophylline—PDE5A—retina—melanoma	0.000755	0.0204	CbGeAlD
Theophylline—Caffeine—PIK3CB—melanoma	0.000744	0.126	CrCbGaD
Theophylline—Caffeine—PIK3CD—melanoma	0.000744	0.126	CrCbGaD
Theophylline—ADA—mammalian vulva—melanoma	0.00073	0.0198	CbGeAlD
Theophylline—HDAC2—eye—melanoma	0.000714	0.0193	CbGeAlD
Theophylline—HDAC2—retina—melanoma	0.000707	0.0191	CbGeAlD
Theophylline—Atrial fibrillation—Vemurafenib—melanoma	0.000703	0.0237	CcSEcCtD
Theophylline—PDE4C—head—melanoma	0.000653	0.0177	CbGeAlD
Theophylline—Extravasation—Bleomycin—melanoma	0.000638	0.0215	CcSEcCtD
Theophylline—HDAC2—skin of body—melanoma	0.000621	0.0168	CbGeAlD
Theophylline—Extravasation—Dactinomycin—melanoma	0.000595	0.02	CcSEcCtD
Theophylline—Caffeine—PIK3CA—melanoma	0.000576	0.0977	CrCbGaD
Theophylline—ADORA2B—head—melanoma	0.000571	0.0154	CbGeAlD
Theophylline—Extravasation—Carmustine—melanoma	0.000557	0.0188	CcSEcCtD
Theophylline—ADA—head—melanoma	0.000522	0.0141	CbGeAlD
Theophylline—PDE3B—lymph node—melanoma	0.000483	0.0131	CbGeAlD
Theophylline—Supraventricular tachycardia—Docetaxel—melanoma	0.000476	0.0161	CcSEcCtD
Theophylline—ADORA2A—head—melanoma	0.000475	0.0129	CbGeAlD
Theophylline—Phlebitis—Bleomycin—melanoma	0.000469	0.0158	CcSEcCtD
Theophylline—CYP1B1—eye—melanoma	0.000458	0.0124	CbGeAlD
Theophylline—Disorientation—Bleomycin—melanoma	0.000451	0.0152	CcSEcCtD
Theophylline—Coma—Carmustine—melanoma	0.000444	0.015	CcSEcCtD
Theophylline—Phlebitis—Dactinomycin—melanoma	0.000437	0.0147	CcSEcCtD
Theophylline—PDE5A—head—melanoma	0.000433	0.0117	CbGeAlD
Theophylline—PDE4B—mammalian vulva—melanoma	0.000424	0.0115	CbGeAlD
Theophylline—ADORA1—head—melanoma	0.00041	0.0111	CbGeAlD
Theophylline—Phlebitis—Carmustine—melanoma	0.000409	0.0138	CcSEcCtD
Theophylline—Alopecia—Vemurafenib—melanoma	0.000407	0.0137	CcSEcCtD
Theophylline—HDAC2—head—melanoma	0.000405	0.011	CbGeAlD
Theophylline—PDE4D—lymph node—melanoma	0.000403	0.0109	CbGeAlD
Theophylline—CYP1B1—skin of body—melanoma	0.000399	0.0108	CbGeAlD
Theophylline—ADA—lymph node—melanoma	0.000366	0.00989	CbGeAlD
Theophylline—Dermatitis exfoliative—Temozolomide—melanoma	0.000361	0.0122	CcSEcCtD
Theophylline—Extravasation—Docetaxel—melanoma	0.000358	0.0121	CcSEcCtD
Theophylline—PDE4A—lymph node—melanoma	0.000356	0.00964	CbGeAlD
Theophylline—Anaphylactic shock—Vemurafenib—melanoma	0.000328	0.011	CcSEcCtD
Theophylline—Infection—Vemurafenib—melanoma	0.000325	0.011	CcSEcCtD
Theophylline—Nervous system disorder—Vemurafenib—melanoma	0.000321	0.0108	CcSEcCtD
Theophylline—Hypokalaemia—Carmustine—melanoma	0.000321	0.0108	CcSEcCtD
Theophylline—Hypokalaemia—Temozolomide—melanoma	0.00031	0.0104	CcSEcCtD
Theophylline—Hypotension—Vemurafenib—melanoma	0.000306	0.0103	CcSEcCtD
Theophylline—PDE4B—head—melanoma	0.000303	0.00821	CbGeAlD
Theophylline—PDE5A—lymph node—melanoma	0.000303	0.0082	CbGeAlD
Theophylline—Haematuria—Bleomycin—melanoma	0.000297	0.01	CcSEcCtD
Theophylline—PDE3A—lymph node—melanoma	0.000295	0.00798	CbGeAlD
Theophylline—ADORA1—lymph node—melanoma	0.000287	0.00777	CbGeAlD
Theophylline—Decreased appetite—Vemurafenib—melanoma	0.000285	0.0096	CcSEcCtD
Theophylline—HDAC2—lymph node—melanoma	0.000284	0.00768	CbGeAlD
Theophylline—CYP1A1—skin of body—melanoma	0.000282	0.00762	CbGeAlD
Theophylline—Hyperglycaemia—Carmustine—melanoma	0.000275	0.00926	CcSEcCtD
Theophylline—Hyperglycaemia—Temozolomide—melanoma	0.000266	0.00895	CcSEcCtD
Theophylline—Phlebitis—Docetaxel—melanoma	0.000263	0.00886	CcSEcCtD
Theophylline—CYP1B1—head—melanoma	0.00026	0.00704	CbGeAlD
Theophylline—Flushing—Bleomycin—melanoma	0.000259	0.00874	CcSEcCtD
Theophylline—Body temperature increased—Vemurafenib—melanoma	0.000259	0.00873	CcSEcCtD
Theophylline—CYP1A1—mammalian vulva—melanoma	0.000257	0.00695	CbGeAlD
Theophylline—Alopecia—Bleomycin—melanoma	0.000247	0.00832	CcSEcCtD
Theophylline—Flushing—Dactinomycin—melanoma	0.000242	0.00815	CcSEcCtD
Theophylline—Hypersensitivity—Vemurafenib—melanoma	0.000241	0.00813	CcSEcCtD
Theophylline—Atrial fibrillation—Docetaxel—melanoma	0.000239	0.00806	CcSEcCtD
Theophylline—Caffeine—CYP1B1—melanoma	0.000234	0.0398	CrCbGaD
Theophylline—Pruritus—Vemurafenib—melanoma	0.000232	0.00781	CcSEcCtD
Theophylline—Alopecia—Dactinomycin—melanoma	0.00023	0.00776	CcSEcCtD
Theophylline—Flushing—Carmustine—melanoma	0.000226	0.00763	CcSEcCtD
Theophylline—Diarrhoea—Vemurafenib—melanoma	0.000224	0.00755	CcSEcCtD
Theophylline—Flushing—Temozolomide—melanoma	0.000219	0.00737	CcSEcCtD
Theophylline—Arrhythmia—Carmustine—melanoma	0.000218	0.00734	CcSEcCtD
Theophylline—Dizziness—Vemurafenib—melanoma	0.000217	0.0073	CcSEcCtD
Theophylline—Alopecia—Carmustine—melanoma	0.000215	0.00726	CcSEcCtD
Theophylline—PDE4B—lymph node—melanoma	0.000212	0.00575	CbGeAlD
Theophylline—Vomiting—Vemurafenib—melanoma	0.000208	0.00702	CcSEcCtD
Theophylline—Alopecia—Temozolomide—melanoma	0.000208	0.00702	CcSEcCtD
Theophylline—Abdominal pain upper—Docetaxel—melanoma	0.000207	0.00697	CcSEcCtD
Theophylline—Rash—Vemurafenib—melanoma	0.000207	0.00696	CcSEcCtD
Theophylline—Dermatitis—Vemurafenib—melanoma	0.000206	0.00696	CcSEcCtD
Theophylline—Headache—Vemurafenib—melanoma	0.000205	0.00692	CcSEcCtD
Theophylline—Tremor—Carmustine—melanoma	0.000199	0.0067	CcSEcCtD
Theophylline—Anaphylactic shock—Bleomycin—melanoma	0.000198	0.00669	CcSEcCtD
Theophylline—Infection—Bleomycin—melanoma	0.000197	0.00665	CcSEcCtD
Theophylline—Agitation—Carmustine—melanoma	0.000195	0.00657	CcSEcCtD
Theophylline—Nausea—Vemurafenib—melanoma	0.000195	0.00656	CcSEcCtD
Theophylline—Tremor—Temozolomide—melanoma	0.000192	0.00648	CcSEcCtD
Theophylline—Anorexia—Bleomycin—melanoma	0.000189	0.00638	CcSEcCtD
Theophylline—Agitation—Temozolomide—melanoma	0.000189	0.00635	CcSEcCtD
Theophylline—Hypotension—Bleomycin—melanoma	0.000185	0.00625	CcSEcCtD
Theophylline—Convulsion—Carmustine—melanoma	0.000184	0.0062	CcSEcCtD
Theophylline—Infection—Dactinomycin—melanoma	0.000184	0.0062	CcSEcCtD
Theophylline—CYP1A1—head—melanoma	0.000184	0.00497	CbGeAlD
Theophylline—CYP1B1—lymph node—melanoma	0.000182	0.00493	CbGeAlD
Theophylline—Palpitations—Temozolomide—melanoma	0.000181	0.00611	CcSEcCtD
Theophylline—Anxiety—Carmustine—melanoma	0.00018	0.00607	CcSEcCtD
Theophylline—Convulsion—Temozolomide—melanoma	0.000178	0.00599	CcSEcCtD
Theophylline—Anorexia—Dactinomycin—melanoma	0.000176	0.00595	CcSEcCtD
Theophylline—Anxiety—Temozolomide—melanoma	0.000174	0.00587	CcSEcCtD
Theophylline—Decreased appetite—Bleomycin—melanoma	0.000173	0.00582	CcSEcCtD
Theophylline—Infection—Carmustine—melanoma	0.000172	0.0058	CcSEcCtD
Theophylline—Tachycardia—Carmustine—melanoma	0.000169	0.0057	CcSEcCtD
Theophylline—CYP2E1—head—melanoma	0.000168	0.00454	CbGeAlD
Theophylline—Anaphylactic shock—Temozolomide—melanoma	0.000167	0.00564	CcSEcCtD
Theophylline—Infection—Temozolomide—melanoma	0.000166	0.00561	CcSEcCtD
Theophylline—Anorexia—Carmustine—melanoma	0.000165	0.00557	CcSEcCtD
Theophylline—Nervous system disorder—Temozolomide—melanoma	0.000164	0.00553	CcSEcCtD
Theophylline—Hypotension—Carmustine—melanoma	0.000162	0.00546	CcSEcCtD
Theophylline—Decreased appetite—Dactinomycin—melanoma	0.000161	0.00542	CcSEcCtD
Theophylline—Anorexia—Temozolomide—melanoma	0.00016	0.00538	CcSEcCtD
Theophylline—Urticaria—Bleomycin—melanoma	0.000158	0.00531	CcSEcCtD
Theophylline—Body temperature increased—Bleomycin—melanoma	0.000157	0.00529	CcSEcCtD
Theophylline—Insomnia—Carmustine—melanoma	0.000157	0.00528	CcSEcCtD
Theophylline—Insomnia—Temozolomide—melanoma	0.000151	0.0051	CcSEcCtD
Theophylline—Gastrointestinal pain—Dactinomycin—melanoma	0.000151	0.0051	CcSEcCtD
Theophylline—Decreased appetite—Carmustine—melanoma	0.000151	0.00508	CcSEcCtD
Theophylline—Abdominal pain—Dactinomycin—melanoma	0.000146	0.00493	CcSEcCtD
Theophylline—Body temperature increased—Dactinomycin—melanoma	0.000146	0.00493	CcSEcCtD
Theophylline—Hypersensitivity—Bleomycin—melanoma	0.000146	0.00493	CcSEcCtD
Theophylline—Decreased appetite—Temozolomide—melanoma	0.000146	0.00491	CcSEcCtD
Theophylline—Flushing—Docetaxel—melanoma	0.000145	0.0049	CcSEcCtD
Theophylline—Gastrointestinal pain—Carmustine—melanoma	0.000142	0.00477	CcSEcCtD
Theophylline—Pruritus—Bleomycin—melanoma	0.00014	0.00473	CcSEcCtD
Theophylline—Arrhythmia—Docetaxel—melanoma	0.00014	0.00472	CcSEcCtD
Theophylline—Alopecia—Docetaxel—melanoma	0.000138	0.00467	CcSEcCtD
Theophylline—Body temperature increased—Carmustine—melanoma	0.000137	0.00462	CcSEcCtD
Theophylline—Abdominal pain—Carmustine—melanoma	0.000137	0.00462	CcSEcCtD
Theophylline—Gastrointestinal pain—Temozolomide—melanoma	0.000137	0.00461	CcSEcCtD
Theophylline—Hypersensitivity—Dactinomycin—melanoma	0.000136	0.0046	CcSEcCtD
Theophylline—Urticaria—Temozolomide—melanoma	0.000133	0.00448	CcSEcCtD
Theophylline—CYP2D6—head—melanoma	0.000133	0.00359	CbGeAlD
Theophylline—Abdominal pain—Temozolomide—melanoma	0.000132	0.00446	CcSEcCtD
Theophylline—Body temperature increased—Temozolomide—melanoma	0.000132	0.00446	CcSEcCtD
Theophylline—CYP1A1—lymph node—melanoma	0.000129	0.00348	CbGeAlD
Theophylline—Hypersensitivity—Carmustine—melanoma	0.000128	0.0043	CcSEcCtD
Theophylline—Diarrhoea—Dactinomycin—melanoma	0.000127	0.00427	CcSEcCtD
Theophylline—Vomiting—Bleomycin—melanoma	0.000126	0.00425	CcSEcCtD
Theophylline—Rash—Bleomycin—melanoma	0.000125	0.00422	CcSEcCtD
Theophylline—Dermatitis—Bleomycin—melanoma	0.000125	0.00421	CcSEcCtD
Theophylline—Hypersensitivity—Temozolomide—melanoma	0.000123	0.00416	CcSEcCtD
Theophylline—Palpitations—Docetaxel—melanoma	0.000121	0.00406	CcSEcCtD
Theophylline—Diarrhoea—Carmustine—melanoma	0.000119	0.004	CcSEcCtD
Theophylline—Pruritus—Temozolomide—melanoma	0.000118	0.00399	CcSEcCtD
Theophylline—Convulsion—Docetaxel—melanoma	0.000118	0.00398	CcSEcCtD
Theophylline—Nausea—Bleomycin—melanoma	0.000118	0.00397	CcSEcCtD
Theophylline—Vomiting—Dactinomycin—melanoma	0.000118	0.00397	CcSEcCtD
Theophylline—Rash—Dactinomycin—melanoma	0.000117	0.00393	CcSEcCtD
Theophylline—Dizziness—Carmustine—melanoma	0.000115	0.00386	CcSEcCtD
Theophylline—Diarrhoea—Temozolomide—melanoma	0.000115	0.00386	CcSEcCtD
Theophylline—Anaphylactic shock—Docetaxel—melanoma	0.000111	0.00375	CcSEcCtD
Theophylline—Dizziness—Temozolomide—melanoma	0.000111	0.00373	CcSEcCtD
Theophylline—Infection—Docetaxel—melanoma	0.000111	0.00373	CcSEcCtD
Theophylline—Vomiting—Carmustine—melanoma	0.00011	0.00371	CcSEcCtD
Theophylline—Nausea—Dactinomycin—melanoma	0.00011	0.00371	CcSEcCtD
Theophylline—Shock—Docetaxel—melanoma	0.00011	0.00369	CcSEcCtD
Theophylline—Rash—Carmustine—melanoma	0.000109	0.00368	CcSEcCtD
Theophylline—Nervous system disorder—Docetaxel—melanoma	0.000109	0.00368	CcSEcCtD
Theophylline—Dermatitis—Carmustine—melanoma	0.000109	0.00368	CcSEcCtD
Theophylline—Tachycardia—Docetaxel—melanoma	0.000109	0.00366	CcSEcCtD
Theophylline—Headache—Carmustine—melanoma	0.000109	0.00366	CcSEcCtD
Theophylline—Vomiting—Temozolomide—melanoma	0.000106	0.00359	CcSEcCtD
Theophylline—Anorexia—Docetaxel—melanoma	0.000106	0.00358	CcSEcCtD
Theophylline—Rash—Temozolomide—melanoma	0.000106	0.00356	CcSEcCtD
Theophylline—Dermatitis—Temozolomide—melanoma	0.000105	0.00355	CcSEcCtD
Theophylline—Headache—Temozolomide—melanoma	0.000105	0.00354	CcSEcCtD
Theophylline—Hypotension—Docetaxel—melanoma	0.000104	0.00351	CcSEcCtD
Theophylline—Nausea—Carmustine—melanoma	0.000103	0.00347	CcSEcCtD
Theophylline—Insomnia—Docetaxel—melanoma	0.000101	0.00339	CcSEcCtD
Theophylline—Nausea—Temozolomide—melanoma	9.94e-05	0.00335	CcSEcCtD
Theophylline—Decreased appetite—Docetaxel—melanoma	9.68e-05	0.00326	CcSEcCtD
Theophylline—Gastrointestinal pain—Docetaxel—melanoma	9.1e-05	0.00307	CcSEcCtD
Theophylline—Abdominal pain—Docetaxel—melanoma	8.8e-05	0.00297	CcSEcCtD
Theophylline—Body temperature increased—Docetaxel—melanoma	8.8e-05	0.00297	CcSEcCtD
Theophylline—Hypersensitivity—Docetaxel—melanoma	8.2e-05	0.00276	CcSEcCtD
Theophylline—Pruritus—Docetaxel—melanoma	7.88e-05	0.00265	CcSEcCtD
Theophylline—Diarrhoea—Docetaxel—melanoma	7.62e-05	0.00257	CcSEcCtD
Theophylline—Dizziness—Docetaxel—melanoma	7.36e-05	0.00248	CcSEcCtD
Theophylline—Vomiting—Docetaxel—melanoma	7.08e-05	0.00239	CcSEcCtD
Theophylline—Rash—Docetaxel—melanoma	7.02e-05	0.00237	CcSEcCtD
Theophylline—Dermatitis—Docetaxel—melanoma	7.01e-05	0.00236	CcSEcCtD
Theophylline—Headache—Docetaxel—melanoma	6.97e-05	0.00235	CcSEcCtD
Theophylline—Caffeine—ABCB1—melanoma	6.72e-05	0.0114	CrCbGaD
Theophylline—Nausea—Docetaxel—melanoma	6.61e-05	0.00223	CcSEcCtD
Theophylline—ADORA1—Signaling Pathways—NRAS—melanoma	3.35e-06	3.16e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—MAPK3—melanoma	3.34e-06	3.15e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—MYC—melanoma	3.33e-06	3.14e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CASP3—melanoma	3.32e-06	3.13e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—STAT3—melanoma	3.32e-06	3.13e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IL2—melanoma	3.32e-06	3.13e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	3.32e-06	3.13e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—NRAS—melanoma	3.31e-06	3.12e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—TP53—melanoma	3.31e-06	3.12e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—KRAS—melanoma	3.29e-06	3.1e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.27e-06	3.08e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—MAPK1—melanoma	3.26e-06	3.08e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—EGFR—melanoma	3.26e-06	3.08e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PIK3CD—melanoma	3.26e-06	3.07e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GNA11—melanoma	3.24e-06	3.06e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—MYC—melanoma	3.24e-06	3.06e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—KRAS—melanoma	3.24e-06	3.05e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CCND1—melanoma	3.23e-06	3.05e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CXCL8—melanoma	3.23e-06	3.04e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GNA11—melanoma	3.22e-06	3.03e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—ALB—melanoma	3.21e-06	3.03e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—MAPK3—melanoma	3.21e-06	3.03e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—HRAS—melanoma	3.21e-06	3.02e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CTNNB1—melanoma	3.2e-06	3.02e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—FASN—melanoma	3.18e-06	2.99e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—MAPK1—melanoma	3.17e-06	2.99e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—EGFR—melanoma	3.17e-06	2.99e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—MAPK3—melanoma	3.17e-06	2.99e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—ABCB1—melanoma	3.16e-06	2.98e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—HRAS—melanoma	3.16e-06	2.98e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.15e-06	2.97e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CDKN1B—melanoma	3.15e-06	2.97e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—FASN—melanoma	3.15e-06	2.97e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—PIK3CA—melanoma	3.14e-06	2.96e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MMP9—melanoma	3.14e-06	2.96e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CDKN1A—melanoma	3.13e-06	2.95e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—SLC5A5—melanoma	3.12e-06	2.95e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—MYC—melanoma	3.12e-06	2.94e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PTEN—melanoma	3.12e-06	2.94e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—PIK3CA—melanoma	3.12e-06	2.94e-05	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—AKT1—melanoma	3.12e-06	2.94e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.11e-06	2.93e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—NFKB1—melanoma	3.11e-06	2.93e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—SLC5A5—melanoma	3.1e-06	2.92e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PRKCA—melanoma	3.09e-06	2.91e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CASP3—melanoma	3.09e-06	2.91e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—MYC—melanoma	3.09e-06	2.91e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IL2—melanoma	3.08e-06	2.91e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—KRAS—melanoma	3.08e-06	2.91e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—IL6—melanoma	3.07e-06	2.89e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—ERCC2—melanoma	3.06e-06	2.89e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—MAPK1—melanoma	3.06e-06	2.88e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—EGFR—melanoma	3.05e-06	2.88e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—IL6—melanoma	3.03e-06	2.85e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—PIK3CA—melanoma	3.02e-06	2.85e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—MAPK1—melanoma	3.02e-06	2.85e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—EGFR—melanoma	3.02e-06	2.85e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GNAQ—melanoma	3.02e-06	2.84e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CD44—melanoma	3.02e-06	2.84e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—TP53—melanoma	3.02e-06	2.84e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CCND1—melanoma	3.01e-06	2.83e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—KRAS—melanoma	3e-06	2.83e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GNAQ—melanoma	2.99e-06	2.82e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CD44—melanoma	2.99e-06	2.82e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CTNNB1—melanoma	2.98e-06	2.81e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—PIK3CA—melanoma	2.97e-06	2.8e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PLA2G6—melanoma	2.96e-06	2.8e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.93e-06	2.76e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—TP53—melanoma	2.93e-06	2.76e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MMP9—melanoma	2.92e-06	2.75e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PRKCA—melanoma	2.91e-06	2.75e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP17A1—melanoma	2.91e-06	2.75e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—HRAS—melanoma	2.91e-06	2.74e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CDKN1A—melanoma	2.91e-06	2.74e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.9e-06	2.74e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PTEN—melanoma	2.9e-06	2.74e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ABCB1—melanoma	2.9e-06	2.74e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CYP1B1—melanoma	2.89e-06	2.73e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—ERCC2—melanoma	2.89e-06	2.72e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—NFKB1—melanoma	2.89e-06	2.72e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—KRAS—melanoma	2.89e-06	2.72e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—HRAS—melanoma	2.88e-06	2.72e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—TP53—melanoma	2.88e-06	2.71e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.87e-06	2.71e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CYP1B1—melanoma	2.87e-06	2.7e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—KRAS—melanoma	2.85e-06	2.69e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PIK3CB—melanoma	2.84e-06	2.68e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	2.83e-06	2.67e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—PIK3CA—melanoma	2.83e-06	2.67e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—AKT1—melanoma	2.83e-06	2.67e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—VEGFA—melanoma	2.82e-06	2.66e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PTGS2—melanoma	2.81e-06	2.65e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—HRAS—melanoma	2.8e-06	2.64e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—STAT3—melanoma	2.79e-06	2.63e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—AKT1—melanoma	2.79e-06	2.63e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—NRAS—melanoma	2.78e-06	2.63e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—IL6—melanoma	2.78e-06	2.63e-05	CbGpPWpGaD
Theophylline—HDAC2—Gene Expression—AKT1—melanoma	2.77e-06	2.61e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—IL6—melanoma	2.76e-06	2.6e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—PIK3CA—melanoma	2.75e-06	2.6e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—HRAS—melanoma	2.75e-06	2.6e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GNA11—melanoma	2.75e-06	2.59e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TP53—melanoma	2.74e-06	2.58e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—FASN—melanoma	2.69e-06	2.54e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—IL6—melanoma	2.68e-06	2.53e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PRKCA—melanoma	2.67e-06	2.52e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MAPK3—melanoma	2.67e-06	2.51e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TP53—melanoma	2.66e-06	2.51e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—VCAN—melanoma	2.66e-06	2.51e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—PIK3CA—melanoma	2.65e-06	2.5e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ERCC2—melanoma	2.65e-06	2.5e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—SLC5A5—melanoma	2.65e-06	2.5e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—IL6—melanoma	2.63e-06	2.48e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—VEGFA—melanoma	2.62e-06	2.47e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—PIK3CA—melanoma	2.62e-06	2.47e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—HRAS—melanoma	2.62e-06	2.47e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—STAT3—melanoma	2.59e-06	2.45e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MYC—melanoma	2.59e-06	2.45e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—NRAS—melanoma	2.59e-06	2.44e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—AKT1—melanoma	2.57e-06	2.42e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TP53—melanoma	2.56e-06	2.42e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GNAQ—melanoma	2.56e-06	2.41e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CD44—melanoma	2.56e-06	2.41e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—HRAS—melanoma	2.55e-06	2.4e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—AKT1—melanoma	2.55e-06	2.4e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MAPK1—melanoma	2.54e-06	2.39e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—EGFR—melanoma	2.54e-06	2.39e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TP53—melanoma	2.53e-06	2.39e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.53e-06	2.39e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—IL6—melanoma	2.51e-06	2.36e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.5e-06	2.36e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.48e-06	2.34e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MAPK3—melanoma	2.48e-06	2.34e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—AKT1—melanoma	2.47e-06	2.33e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—HRAS—melanoma	2.45e-06	2.31e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PTEN—melanoma	2.45e-06	2.31e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP1B1—melanoma	2.45e-06	2.31e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—IL6—melanoma	2.44e-06	2.3e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—AKT1—melanoma	2.43e-06	2.29e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—HRAS—melanoma	2.42e-06	2.29e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CG—melanoma	2.42e-06	2.28e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MYC—melanoma	2.41e-06	2.27e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—KRAS—melanoma	2.4e-06	2.26e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.39e-06	2.26e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ABCB1—melanoma	2.38e-06	2.25e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ABCB1—melanoma	2.36e-06	2.23e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MAPK1—melanoma	2.36e-06	2.22e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—EGFR—melanoma	2.36e-06	2.22e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—IL6—melanoma	2.35e-06	2.21e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PPARG—melanoma	2.34e-06	2.2e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—IL6—melanoma	2.32e-06	2.19e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—AKT1—melanoma	2.31e-06	2.18e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CG—melanoma	2.28e-06	2.15e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—AKT1—melanoma	2.25e-06	2.12e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP17A1—melanoma	2.25e-06	2.12e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—KRAS—melanoma	2.23e-06	2.1e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PIK3CA—melanoma	2.2e-06	2.08e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PPARG—melanoma	2.2e-06	2.08e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.19e-06	2.07e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PRKCA—melanoma	2.19e-06	2.07e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ERCC2—melanoma	2.17e-06	2.05e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PRKCA—melanoma	2.17e-06	2.05e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—AKT1—melanoma	2.17e-06	2.04e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.16e-06	2.04e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ERCC2—melanoma	2.16e-06	2.03e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—AKT1—melanoma	2.14e-06	2.02e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TP53—melanoma	2.13e-06	2.01e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CD—melanoma	2.13e-06	2.01e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GNA11—melanoma	2.12e-06	2e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—ALB—melanoma	2.1e-06	1.98e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CG—melanoma	2.09e-06	1.97e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—FASN—melanoma	2.08e-06	1.96e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PIK3CA—melanoma	2.05e-06	1.93e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—SLC5A5—melanoma	2.04e-06	1.93e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—HRAS—melanoma	2.04e-06	1.92e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PPARG—melanoma	2.02e-06	1.9e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ABCB1—melanoma	2.02e-06	1.9e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CD—melanoma	2.01e-06	1.89e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TP53—melanoma	1.98e-06	1.87e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—ALB—melanoma	1.98e-06	1.87e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CD44—melanoma	1.97e-06	1.86e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GNAQ—melanoma	1.97e-06	1.86e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IL6—melanoma	1.95e-06	1.84e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—HRAS—melanoma	1.89e-06	1.79e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP1B1—melanoma	1.89e-06	1.78e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PRKCA—melanoma	1.86e-06	1.75e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CB—melanoma	1.85e-06	1.75e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ERCC2—melanoma	1.84e-06	1.74e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CD—melanoma	1.84e-06	1.73e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PTGS2—melanoma	1.84e-06	1.73e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ALB—melanoma	1.81e-06	1.71e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IL6—melanoma	1.81e-06	1.71e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—AKT1—melanoma	1.8e-06	1.7e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.79e-06	1.68e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CB—melanoma	1.75e-06	1.65e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PTGS2—melanoma	1.73e-06	1.63e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PIK3CA—melanoma	1.73e-06	1.63e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CG—melanoma	1.72e-06	1.62e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CG—melanoma	1.7e-06	1.61e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—AKT1—melanoma	1.67e-06	1.58e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PPARG—melanoma	1.66e-06	1.56e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PPARG—melanoma	1.64e-06	1.55e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CB—melanoma	1.6e-06	1.51e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PTEN—melanoma	1.6e-06	1.51e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PTGS2—melanoma	1.59e-06	1.5e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ABCB1—melanoma	1.56e-06	1.47e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.53e-06	1.44e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PTEN—melanoma	1.51e-06	1.42e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CD—melanoma	1.51e-06	1.42e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CD—melanoma	1.5e-06	1.41e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ALB—melanoma	1.49e-06	1.41e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ALB—melanoma	1.48e-06	1.39e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CG—melanoma	1.45e-06	1.37e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PRKCA—melanoma	1.43e-06	1.35e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ERCC2—melanoma	1.42e-06	1.34e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—AKT1—melanoma	1.41e-06	1.33e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PPARG—melanoma	1.4e-06	1.32e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PTEN—melanoma	1.38e-06	1.31e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CB—melanoma	1.32e-06	1.24e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CB—melanoma	1.3e-06	1.23e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PTGS2—melanoma	1.3e-06	1.23e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PTGS2—melanoma	1.29e-06	1.22e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CD—melanoma	1.28e-06	1.21e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ALB—melanoma	1.26e-06	1.19e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PTEN—melanoma	1.14e-06	1.07e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CA—melanoma	1.13e-06	1.07e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PTEN—melanoma	1.13e-06	1.06e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CG—melanoma	1.12e-06	1.06e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CB—melanoma	1.11e-06	1.05e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PTGS2—melanoma	1.1e-06	1.04e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PPARG—melanoma	1.08e-06	1.02e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CA—melanoma	1.07e-06	1e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CD—melanoma	9.87e-07	9.31e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CA—melanoma	9.77e-07	9.21e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ALB—melanoma	9.74e-07	9.19e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PTEN—melanoma	9.63e-07	9.08e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—AKT1—melanoma	9.23e-07	8.71e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—AKT1—melanoma	8.7e-07	8.21e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CB—melanoma	8.6e-07	8.11e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PTGS2—melanoma	8.52e-07	8.04e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CA—melanoma	8.02e-07	7.56e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—AKT1—melanoma	7.98e-07	7.53e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CA—melanoma	7.95e-07	7.5e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PTEN—melanoma	7.43e-07	7.01e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CA—melanoma	6.79e-07	6.41e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—AKT1—melanoma	6.55e-07	6.18e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—AKT1—melanoma	6.49e-07	6.12e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—AKT1—melanoma	5.55e-07	5.23e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CA—melanoma	5.24e-07	4.94e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—AKT1—melanoma	4.28e-07	4.04e-06	CbGpPWpGaD
